Keng L. Ng
Brisbane, QLD, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Correction: Berezowski et al. Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study. Cancers 2025, 17, 2588.
Journal: Cancers
Published: April 27, 2026
Biomarkers in Renal Cell Carcinoma: A Systematic Review and Immunohistochemical Validation Study.
Journal: Cancers
Published: July 01, 2025
Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a retrospective cohort study.
Journal: World journal of urology
Published: March 22, 2025
A mutation panel comprising BRAFV600E, NRASQ61R, and NRASQ61H replicated retrospective histopathological examination findings in differentiating benign goitre from malignant papillary thyroid cancer in a cohort of Malaysian patients.
Journal: The Malaysian journal of pathology
Published: December 28, 2023
Feasibility of Aquablation prostate surgery performed as day cases.
Journal: BJU international
Published: December 20, 2023
Integrative analysis of deoxyribonuclease 1-like 3 as a potential biomarker in renal cell carcinoma.
Integrative analysis of deoxyribonuclease 1-like 3 as a potential biomarker in renal cell carcinoma.
Journal: Translational andrology and urology
Published: June 22, 2023
A nationwide survey on awareness and knowledge about Bronchial Provocation Test amongst doctors in Malaysia.
Journal: The Medical journal of Malaysia
Published: January 28, 2022
Two-dimensional correlated spectroscopy distinguishes clear cell renal cell carcinoma from other kidney neoplasms and non-cancer kidney.
Journal: Translational andrology and urology
Published: December 06, 2021
Initial single centre experience of Aquablation of the prostate using the AquaBeam system with athermal haemostasis for the treatment of benign prostatic hyperplasia: 1-year outcomes.
Journal: World journal of urology
Published: August 31, 2020
A Simple Clinical Tool for Stratifying Risk of Clinically Significant CKD after Nephrectomy: Development and Multinational Validation.
Journal: Journal of the American Society of Nephrology : JASN
Published: December 22, 2019
Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Journal: Translational andrology and urology
Published: June 26, 2019
Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis.
Journal: Translational andrology and urology
Published: June 26, 2019
Last Updated: 09/26/2026